Concepts (118)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Central Nervous System Neoplasms | 7 | 2022 | 895 | 1.700 |
Why?
|
| Brain Neoplasms | 14 | 2024 | 8829 | 1.110 |
Why?
|
| Germinoma | 3 | 2022 | 133 | 1.050 |
Why?
|
| Glioma | 8 | 2023 | 3388 | 1.000 |
Why?
|
| Neoplasms, Germ Cell and Embryonal | 3 | 2022 | 484 | 0.870 |
Why?
|
| Pyrimidinones | 1 | 2020 | 370 | 0.630 |
Why?
|
| Astrocytoma | 1 | 2023 | 789 | 0.620 |
Why?
|
| Ependymoma | 1 | 2021 | 333 | 0.610 |
Why?
|
| Hemodiafiltration | 1 | 2016 | 20 | 0.580 |
Why?
|
| Cranial Irradiation | 1 | 2019 | 401 | 0.570 |
Why?
|
| Neoplasm Recurrence, Local | 6 | 2021 | 9185 | 0.550 |
Why?
|
| Testicular Neoplasms | 1 | 2022 | 761 | 0.550 |
Why?
|
| Ifosfamide | 1 | 2016 | 225 | 0.550 |
Why?
|
| Pyridones | 1 | 2020 | 712 | 0.530 |
Why?
|
| Cerebellar Neoplasms | 1 | 2019 | 585 | 0.490 |
Why?
|
| Medulloblastoma | 1 | 2019 | 681 | 0.480 |
Why?
|
| Salvage Therapy | 1 | 2020 | 1269 | 0.460 |
Why?
|
| Hemangioma, Capillary | 1 | 2013 | 61 | 0.430 |
Why?
|
| Neuroblastoma | 2 | 2021 | 1225 | 0.430 |
Why?
|
| Paraneoplastic Cerebellar Degeneration | 1 | 2012 | 15 | 0.430 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 4 | 2019 | 11472 | 0.420 |
Why?
|
| Antineoplastic Agents, Alkylating | 1 | 2016 | 627 | 0.420 |
Why?
|
| Remission Induction | 1 | 2016 | 2384 | 0.370 |
Why?
|
| Nervous System Diseases | 2 | 2022 | 1617 | 0.360 |
Why?
|
| Antibodies, Monoclonal, Murine-Derived | 1 | 2012 | 694 | 0.330 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2016 | 1515 | 0.300 |
Why?
|
| Child | 22 | 2024 | 77478 | 0.290 |
Why?
|
| Brain Diseases | 1 | 2016 | 1554 | 0.290 |
Why?
|
| Antineoplastic Agents | 3 | 2020 | 13655 | 0.260 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2020 | 5163 | 0.260 |
Why?
|
| Child, Preschool | 13 | 2023 | 40955 | 0.260 |
Why?
|
| Hodgkin Disease | 1 | 2012 | 1413 | 0.240 |
Why?
|
| Histiocytic Disorders, Malignant | 1 | 2022 | 16 | 0.210 |
Why?
|
| Choriocarcinoma | 1 | 2022 | 123 | 0.210 |
Why?
|
| Neurosurgical Procedures | 1 | 2013 | 2002 | 0.200 |
Why?
|
| Brain Stem Neoplasms | 1 | 2024 | 204 | 0.200 |
Why?
|
| Prognosis | 6 | 2023 | 29010 | 0.200 |
Why?
|
| Retrospective Studies | 12 | 2023 | 77098 | 0.190 |
Why?
|
| Adolescent | 14 | 2023 | 85649 | 0.190 |
Why?
|
| Gangliosides | 1 | 2021 | 140 | 0.190 |
Why?
|
| Isocitrate Dehydrogenase | 2 | 2023 | 870 | 0.180 |
Why?
|
| Young Adult | 11 | 2023 | 56350 | 0.160 |
Why?
|
| Central Nervous System | 2 | 2022 | 1354 | 0.160 |
Why?
|
| Infant | 8 | 2022 | 35070 | 0.160 |
Why?
|
| Teratoma | 1 | 2020 | 387 | 0.150 |
Why?
|
| Treatment Failure | 1 | 2022 | 2615 | 0.140 |
Why?
|
| Radiotherapy Dosage | 2 | 2021 | 2876 | 0.140 |
Why?
|
| Pathology, Molecular | 1 | 2019 | 325 | 0.140 |
Why?
|
| Mitoxantrone | 1 | 2016 | 149 | 0.140 |
Why?
|
| Methylene Blue | 1 | 2016 | 155 | 0.140 |
Why?
|
| Autopsy | 1 | 2019 | 1006 | 0.130 |
Why?
|
| Benzimidazoles | 1 | 2020 | 848 | 0.130 |
Why?
|
| Drug Resistance | 1 | 2021 | 1608 | 0.130 |
Why?
|
| Asparaginase | 1 | 2016 | 235 | 0.130 |
Why?
|
| Vinblastine | 1 | 2016 | 490 | 0.120 |
Why?
|
| Humans | 27 | 2024 | 742088 | 0.120 |
Why?
|
| Follow-Up Studies | 3 | 2020 | 39004 | 0.120 |
Why?
|
| Protein Kinase Inhibitors | 4 | 2022 | 5522 | 0.120 |
Why?
|
| Antibodies | 1 | 2021 | 2459 | 0.110 |
Why?
|
| Adult | 12 | 2023 | 213712 | 0.110 |
Why?
|
| Male | 14 | 2022 | 349538 | 0.100 |
Why?
|
| Sarcoma | 1 | 2022 | 1895 | 0.090 |
Why?
|
| Nausea | 1 | 2013 | 665 | 0.090 |
Why?
|
| Dacarbazine | 1 | 2013 | 567 | 0.090 |
Why?
|
| Vomiting | 1 | 2013 | 632 | 0.090 |
Why?
|
| Immunotherapy | 2 | 2024 | 4414 | 0.090 |
Why?
|
| Dexamethasone | 1 | 2016 | 1949 | 0.080 |
Why?
|
| Female | 12 | 2022 | 379592 | 0.080 |
Why?
|
| Mutation | 5 | 2023 | 29717 | 0.080 |
Why?
|
| Medical Oncology | 1 | 2019 | 2235 | 0.080 |
Why?
|
| Glioblastoma | 1 | 2022 | 3456 | 0.070 |
Why?
|
| Genomics | 1 | 2023 | 5692 | 0.070 |
Why?
|
| Neuropsychological Tests | 1 | 2019 | 6974 | 0.070 |
Why?
|
| Chronic Disease | 1 | 2021 | 9144 | 0.070 |
Why?
|
| Headache | 1 | 2013 | 1219 | 0.060 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2013 | 3471 | 0.060 |
Why?
|
| Recurrence | 1 | 2016 | 8333 | 0.060 |
Why?
|
| Immunologic Factors | 2 | 2024 | 1575 | 0.060 |
Why?
|
| Proto-Oncogene Proteins B-raf | 2 | 2023 | 2028 | 0.060 |
Why?
|
| Tryptophan | 1 | 2024 | 478 | 0.050 |
Why?
|
| Neurofibroma, Plexiform | 1 | 2020 | 69 | 0.050 |
Why?
|
| Ribonuclease III | 1 | 2022 | 275 | 0.050 |
Why?
|
| Pinealoma | 1 | 2020 | 54 | 0.050 |
Why?
|
| Antibody-Dependent Cell Cytotoxicity | 1 | 2021 | 304 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2022 | 647 | 0.040 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2022 | 375 | 0.040 |
Why?
|
| Basal Ganglia | 1 | 2021 | 545 | 0.040 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2022 | 1086 | 0.040 |
Why?
|
| Oncogenes | 1 | 2022 | 1263 | 0.040 |
Why?
|
| Endocytosis | 1 | 2021 | 983 | 0.040 |
Why?
|
| Thalamus | 1 | 2021 | 1023 | 0.030 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2022 | 1581 | 0.030 |
Why?
|
| DNA Mutational Analysis | 1 | 2021 | 4187 | 0.030 |
Why?
|
| Killer Cells, Natural | 1 | 2021 | 2133 | 0.030 |
Why?
|
| Treatment Outcome | 2 | 2020 | 62966 | 0.020 |
Why?
|
| Time Factors | 1 | 2013 | 40054 | 0.020 |
Why?
|
| Base Sequence | 1 | 2022 | 12797 | 0.020 |
Why?
|
| Molecular Targeted Therapy | 1 | 2022 | 2723 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2021 | 5975 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2013 | 20086 | 0.020 |
Why?
|
| Leukocytes | 1 | 2018 | 2039 | 0.020 |
Why?
|
| Neutrophils | 1 | 2021 | 3711 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2021 | 3585 | 0.020 |
Why?
|
| Antigens, CD | 1 | 2018 | 4024 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2022 | 7716 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2013 | 35342 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2018 | 8621 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2018 | 10943 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2021 | 16665 | 0.020 |
Why?
|
| Antibodies, Monoclonal | 1 | 2021 | 9274 | 0.010 |
Why?
|
| Biomedical Research | 1 | 2019 | 3306 | 0.010 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2020 | 5171 | 0.010 |
Why?
|
| Disease Progression | 1 | 2018 | 13256 | 0.010 |
Why?
|
| Middle Aged | 2 | 2023 | 213127 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2018 | 25575 | 0.010 |
Why?
|
| Lung Neoplasms | 1 | 2020 | 13019 | 0.010 |
Why?
|
| United States | 1 | 2022 | 69693 | 0.010 |
Why?
|
| Aged | 1 | 2023 | 162944 | 0.010 |
Why?
|
Concepts
(118)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(40)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_